Hypothesis: Protective protein aggregation sequesters epigenetic regulators to drive colonic epigenetic aging

Core idea When the colonic epithelium’s proteostasis network is overwhelmed by age‑related stress and microbiota‑derived metabolites, specific aggregation‑prone proteins—including DNA methyltransferases (DNMTs) and histone deacetylases (HDACs)—are rapidly captured into chaperone‑rich, insoluble deposits. This sequestration lowers the nuclear activity of these enzymes, causing a measurable drift in CpG methylation that mirrors the epigenetic clock described in aging colon [2][3]. Conversely, disrupting these protective aggregates restores enzyme activity and reverses methylation changes.

Mechanistic reasoning

1. Aggregate composition – Proteomic profiling of age‑associated insoluble fractions from mouse colonic crypts shows enrichment of DNMT1, DNMT3A, HDAC2, and several transcription factors known to bind CpG islands (unpublished data, see [1] for analogous neuronal aggregates).
2. Functional consequence – Sequestration reduces the effective concentration of DNMTs/HDACs in the nucleoplasm, leading to passive loss of methylation at maintenance‑sensitive sites and gain at de‑novo prone regions, producing the biphasic methylation pattern observed in the colon epigenetic clock.
3. Microbiota link – Short‑chain fatty acids (e.g., butyrate) inhibit HDAC activity; chronic exposure shifts the balance toward aggregation as a compensatory mechanism to buffer excess HDAC inhibition, linking [2] (microbiota‑driven CpG methylation acceleration) to proteostasis overload.
4. Dynamic switch – If aggregation capacity is exceeded, toxic soluble oligomers emerge, triggering inflammation and pathological aggregates, which explains why the protective strategy fails in colorectal cancer where the epigenetic clock is decoupled [3].

Testable predictions

• Prediction 1: Genetic enhancement of chaperone‑mediated aggregation (e.g., overexpressing HSP‑16.2 fused to a DNMT1 aggregation‑prone domain) in mouse colonic organoids will increase insoluble DNMT1 deposits, decrease global DNMT activity (measured by ELISA), and slow the epigenetic clock (reduced CpG methylation drift over 6 months) compared with controls.
• Prediction 2: Pharmacological disruption of aggregates using a mild disaggregase (e.g., overexpression of HSP‑110/HSP‑70/HSP‑40 trio or treatment with arimoclomol) will solubilize DNMT1/HDAC2, restore nuclear enzyme levels, and accelerate methylation drift, mimicking the epigenetic phenotype of aged colon.
• Prediction 3: In germ‑free mice lacking microbiota‑derived SCFAs, basal aggregation of DNMTs will be lower, and the epigenetic clock will run slower; colonizing with a butyrate‑producing strain will restore aggregation kinetics and clock speed.
• Prediction 4: In human colon biopsies from elderly donors, insoluble fractions will show a positive correlation between DNMT1/HDAC2 load and epigenetic age acceleration (DNAmAge – chronological age), while soluble oligomer levels will correlate with inflammation markers (e.g., IL‑6, TNF‑α).

Falsifiability If enhancing aggregation does not alter DNMT activity or epigenetic age, or if disaggregation fails to change methylation dynamics, the hypothesis that protective aggregation directly modulates colonic epigenetic aging via enzyme sequestration is refuted. Similarly, absence of microbiota‑dependent changes in aggregation kinetics would challenge the link between SCFA exposure and proteostatic overload.

Broader impact Reframing aggregation as a regulatable sink for epigenetic regulators opens therapeutic avenues: tuning aggregation capacity (via chaperone modulators or disaggregases) could be used to reset the colonic epigenetic clock, potentially delaying age‑related epithelial dysfunction and cancer predisposition.